Avinger, Inc.

AVGR | NASDAQ | 0 Followers
$0.47 -20.74% -$0.12
Follow
Loading...

Profile

Avinger, Inc. (AVGR) is a medical device company focused on the development and commercialization of advanced medical devices for the diagnosis and treatment of cardiovascular diseases. Their main product is lumivascular technology, which combines imaging and therapy for precise diagnosis and treatment of vascular diseases such as peripheral artery disease and coronary artery disease. The Avinger lumivascular system allows physicians to precisely visualize vascular structures and navigate medical catheters through vascular blockages and narrowings to restore blood flow and improve clinical outcomes for patients with cardiovascular diseases. Avinger, Inc. focuses on innovative technologies and therapeutic solutions for the treatment of vascular diseases and providing effective tools for interventional cardiology.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade